diabetes

Novo Nordisk sees chance of U.S. Tresiba launch before rival products
Yahoo/Reuters
Thu, 03/20/14 - 05:35 pm
Novo Nordisk
insulin
diabetes
Tresiba
Lantus
Sanofi
Eli Lilly
MLV Sees A Good Chance Of FDA Approval For MannKind's Afrezza And 60% Upside
Seeking Alpha
Tue, 03/18/14 - 12:14 pm
FDA
MannKind
Afrezza
diabetes
MannKind: The Gambler's Creed - Let It Ride
Seeking Alpha
Fri, 03/14/14 - 10:54 am
MannKind
Afrezza
diabetes
Biotech Stock Mailbag Extra: MannKind's Afrezza Panel Setup
TheStreet.com
Thu, 03/6/14 - 10:28 am
advisory panels
FDA
Afrezza
diabetes
MannKind
inhaled insulin
Can Diabetes Treatments Replace Patent Losses At Eli Lilly & Co?
Motley Fool
Thu, 03/6/14 - 10:17 am
Eli Lilly
diabetes
patents
dulaglutide
GLP-1 agonist
Novo Nordisk
AstraZeneca
GSK
JNJ
Lilly’s Diabetes Pill Rejected by FDA Over Manufacturing
Bloomberg
Wed, 03/5/14 - 11:44 am
FDA
Eli Lilly
diabetes
empagliflozin
Boehringer Ingelheim
Boston Therapeutics to initiate Phase II clinical study of BTI-320 in U.S.
The Fly on the Wall
Tue, 03/4/14 - 09:18 am
Boston Therapeutics
BTI-320
diabetes
AstraZeneca announces FDA approval of Bydureon Pen
The Fly on the Wall
Mon, 03/3/14 - 10:05 am
FDA
diabetes
AstraZeneca
Bydureon
Bydureon pen
Type 2 Diabetes Gene Mutations Seen as Drugmaker Target
Bloomberg
Mon, 03/3/14 - 08:30 am
diabetes
type 2 diabetes
Pfizer
Eli Lilly Gains Slightly on Dulaglutide Data
Yahoo/Zacks.com
Thu, 02/27/14 - 04:56 pm
Eli Lilly
dulaglutide
diabetes
FDA eases worries regarding certain diabetes medications
Yahoo/Fly on the Wall
Thu, 02/27/14 - 08:19 am
FDA
diabetes
Merck
Januvia
Janumet
Novo Nordisk
Victoza
Bristol-Myers Squibb
Byetta
Bydureon
Who loses most in Lilly vs. Novo diabetes study? AstraZeneca
Fierce Pharma
Wed, 02/26/14 - 07:03 pm
Victoza
Novo Nordisk
Eli Lilly
dulaglutide
diabetes
Bydureon
AstraZeneca
Clock Is Ticking For AstraZeneca
Forbes
Tue, 02/25/14 - 03:57 pm
AstraZeneca
dulaglutide
GSK
Eli Lilly
Bydureon
diabetes
Lilly weekly diabetes drug succeeds vs market leader Victoza -study
Yahoo/Reuters
Tue, 02/25/14 - 08:15 am
Eli Lilly
diabetes
Victoza
Novo Nordisk
dulaglutide
5 Questions for MannKind
Motley Fool
Thu, 02/20/14 - 08:21 am
MannKind
Afrezza
diabetes
Poor Pipeline Management Imperils Lilly's Future Cash Flows
Motley Fool
Mon, 02/17/14 - 03:22 pm
Eli Lilly
diabetes
insulin
Novo Nordisk
Sanofi
oncology
Alzheimer's disease
Echo Therapeutics Facing Major Execution Risks In A Very Competitive Market
Seeking Alpha
Fri, 02/14/14 - 06:34 pm
Echo Therapeutics
blood glucose monitoring
devices
diabetes
FDA to review possible heart risks with AstraZeneca's diabetes drug
Yahoo/Reuters
Tue, 02/11/14 - 10:35 am
FDA
AstraZeneca
diabetes
Onglyza
Merck joins race to copy Sanofi's diabetes drug Lantus
Yahoo/Reuters
Mon, 02/10/14 - 12:02 pm
Lantus
diabetes
Sanofi
Merck
Merck and Samsung Bioepis Enter Collaboration Agreement to Develop and Commercialize Insulin Glargine Candidate for Diabetes
Yahoo
Mon, 02/10/14 - 09:14 am
Merck
Samsung Bioepis
R&D
diabetes
MK-1293
insulin glargine

Pages